An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes. Callebaut A, Guyer P, Baker RL, Gallegos JB, et al. Diabetes 2024 Jan 31:db230622. doi: 10.2337/db23-0622.

Read + Share

Amedeo Smart

Independent Medical Education

Callebaut A, Guyer P, Baker RL, Gallegos JB, et al. An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes. Diabetes 2024 Jan 31:db230622. doi: 10.2337/db23-0622.
PMID: 38295386